Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 365 Issue 6441, 2 September 1993

Opinion

  • By imposing an economic ban on China in retaliation for the alleged sale of missile parts to Pakistan, the United States has done the right thing, but has gone only half-way towards the goal of limiting the spread of weapons.

    Opinion

    Advertisement

  • President Bill Clinton must fight to win agreement to the free-trade pact with Canada and Mexico.

    Opinion
  • Contrary to popular belief, the nuclear industry is not dead. It needs to be kept alive.

    Opinion
Top of page ⤴

News

Top of page ⤴

Correspondence

Top of page ⤴

News & Views

Top of page ⤴

Scientific Correspondence

Top of page ⤴

Book Review

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Nature Genetics

  • The genetics of inherited migraines is proving more tractable than might have been expected given the clinical heterogeneity of the malady.

    • Adrian J. Ivinson
    Nature Genetics
Top of page ⤴

Product Review

  • The simple aggregation of pluripotent ES ßcells with morulae-stage embryos can result in viable chimaeras at a similar frequency to that of blastocyst injection. The savings in time and equipment inherent in the aggregation techniques, however, make this approach well worth considering.

    • Stephen A. Wood
    • Nick D. Allen
    • Andras Nagy
    Product Review
  • Cell culture systems for the growth of endothelial cells and keratinocytes, a reagent for the removal of free label from antibody-label conjugate preparations and a radiochromatography flow monitor are featured this week.

    • Diane Gershon
    Product Review
Top of page ⤴
Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links